ScreenIn3D Innovation Draws Accolades

ScreenIn3D, a partner of AMSBIO, reports on the accolades it has received following the recent launch of its novel microfluidic cancer screening service. Combining the latest advances in microfluidics and 3D culture - the service uses an optimised screening platform targeted at improving anticancer drug treatment and accelerating development of new personalised medicine solutions. At the recent Miptec conference in Basle, Switzerland - ScreenIn3D was one of 60 global organisations invited to showcase its cutting-edge life science technologies....

Original Article: ScreenIn3D Innovation Draws Accolades

More From BioPortfolio on "ScreenIn3D Innovation Draws Accolades"